KSA and UAE Health & Wellness Food & Beverage Market to Reach $14.56 Billion, Reveals Frost & Sullivan

صاغت حكومات دول مجلس التعاون الخليجي تشريعات لتعزيز الوعي حول بدائل غذائية صحية أكثر، ما أدى إلى تحقيق فرص نمو هائلة



دبي، الإمارات العربية المتحدة، -الخميس 30 أبريل 2020 [ ايتوس واير ]

يسلّط التحليل الأخير الصادر عن شركة "فروست آند سوليفان"، بعنوان "توقعات قطاع الأغذية والمشروبات القائمة على الصحة والعافية في المملكة العربية السعودية والإمارات العربية المتحدة لعام 2020"، الضوء على عادات المستهلكين المتغيرة والهيئات التشريعية في دول مجلس التعاون الخليجي، ما يشدد على أهمية أسلوب الحياة الصحي. وبحلول أواخر عام 2020، من المتوقع أن تبلغ قيمة سوق والأغذية والمشروبات القائمة على الصحة والعافية في هذه المنطقة إلى 14.56 مليار دولار أمريكي بمعدل نمو سنوي مرّكب يبلغ 10.9 في المائة. تشكّل الإمارات العربية المتحدة والمملكة العربية السعودية مجتمعة نحو 85 في المائة من سوق الصحة والعافية في دول مجلس التعاون الخليجي. علاوة على ذلك، يشهد قطاع المشروبات ذات الصلة بالصحة في دول مجلس التعاون الخليجي نمواً بمعدل أسرع نسبياً من السوق العالمية للأغذية والمشروبات القائمة على الصحة والعافية بنسبة 6.2 في المائة. من المتوقع أن يقدّم قطاع الوجبات الخفيفة والمقبلات أعلى معدل نمو سنوي مرّكب للصحة والعافية بمعدل 7.2 في المائة، يليه عن كثب قطاعات السلع الجاهزة والمصّنعة.

لمزيد من المعلومات حول هذا التحليل، يرجى زيارة الموقع الإلكتروني التالي: http://frost.ly/433

في حين تبنت الشركات العالمية العملاقة من قبيل "نستله" الشرق الأوسط و"دو" و"جلوبال فودز" و"هنتر فودز"، مقاربة الانتظار والمراقبة لمعرفة إمكانات السوق، تعتمد الجهات الإقليمية الفاعلة، من ضمنها قطاع الخدمات الغذائية، استراتيجيات واضحة لتلبية المطالب المتزايدة لقاعدة المستهلكين، حيث تُعتبر هذه الاستراتيجيات أكثر ارتباطاً ووعياً حول الصحة.

وفي هذا السياق، قال ساتفيك جايتلي، استشاري في شؤون الكيماويات والمواد والتغذية في شركة "فروست آند سوليفان": "ساهمت الجهود الاستباقية التي بذلتها حكومات دول مجلس التعاون الخليجي في صياغة تشريعات لتعزيز الوعي بالأغذية الصحية التي توّفر فوائد طبية، وذلك بسبب الارتفاع المفاجىء في الحوادث الناجمة عن اضطرابات أساليب الحياة في المنطقة، مثل أمراض القلب والأوعية الدموية واضطرابات العظام والمفاصل وال"ديابيزيتي" (وهو مزيج بين مرض السكري والسمنة). وأضاف: "نتوقع أن تكون الأعوام الخمسة المقبلة حاسمة، في الوقت الذي ستصبح فيه سوق الأغذية والمشروبات القائمة على الصحة والعافية أكثر انتشاراً بفضل زيادة وعي المستهلكين المتأثر بوسائل التواصل الاجتماعي وبالمستهلكين المتصلين ".

للاستفادة من هذه السوق، يجب على البائعين والشركات المستجدة في السوق:

الاستفادة من الاتجاهات الواعية حول السعرات الحرارية والمواد العضوية لإعادة صياغة مصفوفة المنتجات الحالية لإعداد المستهلكين للابتعاد عن الأطعمة المصّنعة والوجبات الخفيفة.
التركيز على تقليل استهلاك الملح والدهون من خلال استخدام الحلول القائمة على الأبحاث والتطوير في بعض الفئات إسوة بالوجبات الخفيفة والحبوب والحلويات.
إنشاء منتجات واستراتيجيات تسويقية مميزة تركّز على القطاع الفرعي المتنامي من الأغذية والمشروبات القائمة على الصحة والعافية.
تقديم فكرة الأطعمة المخبوزة كبديل صحي عن المنتجات المقلية للأطعمة التي تندرج ضمن فئة "الوجبات الخفيفة".
فهم سلوك المستهلك ونقاطه التحفيزية من خلال التعمّق في تفضيلاته الحالية.


ويُعد التحليل بعنوان "توقعات قطاع الأغذية والمشروبات القائمة على الصحة والعافية في المملكة العربية السعودية والإمارات العربية المتحدة لعام 2020" أحدث إضافة إلى تحليلات وأبحاث شركة "فروست آند سوليفان" للكيماويات والمواد والتغذية المتاحة بواسطة مجلس قيادة "فروست آند سوليفان"، الذي يساعد المنظمات على تحديد التدفق المستمر لفرص النمو وتحقيق النجاح في مستقبل لا يمكن التنبؤ به.

لمحة عن "فروست آند سوليفان"

اشتُهرت "فروست آند سوليفان" عالميّاً على مدى أكثر من خمسة عقود بدورها في مساعدة المستثمرين ورؤساء الشركات والحكومات على اجتياز التغيرات الاقتصادية وتحديد التقنيات التي تحدث تغييراً جذرياً والتوجّهات الكُبرى، ونماذج الأعمال الجديدة، والشركات المستعدة للعمل، لتحقيق تدفقٍ مستمر لفرص النمو لتعزيز النجاح المستقبلي. تواصلوا معنا وابدأوا المحادثة.

"توقعات قطاع الأغذية والمشروبات القائمة على الصحة والعافية في المملكة العربية السعودية والإمارات العربية المتحدة لعام 2020"

"بيه إيه إف 9"




Contacts
نيميشا إيير

هاتف: +919820050519

البريد الإلكتروني: nimisha.iyer@frost.com

الموقع الإلكتروني: http://ww2.frost.com






الرابط الثابت : https://www.aetoswire.com/ar/news/وفقا-ل-فروست-آند-سوليفان-من-المتوقع-أن-تصل-قيمة-سوق-الأغذية-والمشروبات-القائمة-على-الصحة-والعافية-في-المملكة-العربية-السعودية-والإمارات-العربية-المتحدة-إلى-1456-مليار-دولار-أمريكي/ar

TECNO unveils CAMON 15 Pro via online launch – a first in the UAE amid Corona crisis

Dubai, United Arab Emirates-Thursday 30 April 2020 [ AETOS Wire ]

Global premier mobile phone brand TECNO Mobile unveiled a new smartphone: the CAMON 15 series to its global audience in its first online product launch in the United Arab Emirates (UAE) since the Covid-19 lockdown took effect.

As expected, the new CAMON 15 series did not disappoint. Staying true to its tradition, the new smartphone comes equipped with a 48MP SONY camera and trademarked TAIVOS™ technology, which enables up to 15-frame synth with an imaging time of just 4.68 seconds.

 “As a pioneer in the smartphone industry, TECNO Mobile is committed to bringing the latest cutting-edge technology smartphone to its global users, and exploring innovative approaches and channels to support consumers discovering its products for the first time. The first online product launch is a new breakthrough that TECNO brings to its fans globally: a real-time hands-on experience and DEMO of what they can achieve with a smartphone camera, powerful imaging hardware, and a device designed to deliver unprecedented performance for mobile photography fans,” said Stephen Ha, General Manager of TECNO.

Feature-packed phone

In the 30-minute live stream launch watched by thousands of people, TECNO unveiled the CAMON 15 Pro, which boasts a 32MP Clear Lens front camera that “POPs-UP” from the body. The selfie camera also features newly upgraded facial algorithms and a new HDR with built-in natural beauty effects, saving your time for more retouch. It also has a smart anti-fall reaction and a strong resistance to magnetic interference.

Its 48MP, 8x zoom main camera is equipped with TECNO’s signature Ultra Clear Shot, Ultra Night Shot, Super HDR, and AI Scene Detection features, which creates super high-resolution photography and compensates for changing light conditions. It also has a large ½-inch sensor recognizes and captures more light.

The new CAMON 15 also features the TECNO AI Vision Optimization Solution (TAVIOS™) that enables up to 15-frame synth with an imaging time of just 4.68 seconds -- most other smartphones only achieve this in 5.5 seconds or maybe even 7 seconds.

This technology is ideal for night photography since the TAIVOS™ feature is able to filter out image noise and optimize image clarity to deliver clear, balanced, vivid photographs even in low- to lower-light conditions.

Some of its key features include the 6.6" Perfect Fullview, which provides a wider, clearer, and more colorful visual experience and a 5MP Super Wide angle secondary 115-degree camera, which distortion-eliminating close-up shots. Its 91.2% super screen ratio also gives users a truly boundless screen.

The CAMON 15 Pro also comes packed with AI Detection, AI Light Recognition, AI Image Stabilization, and AI Image Processing, which enhance the user’s photographic experience. It also has short video recording capability that supports wide-angle recording.

Other notable features also include the CAMON 15 Pro’s Beautification 3.0, which, with the help of beauty enhancement algorithm, can recognizes a total of 18 unique structural elements in human faces, using 3D stereoscopic beautification and smart tone enhancement to help highlight natural features.

To stimulate interesting and fun social interactions, the new CAMON 15 Pro also come with an additional 12 AR Stickers and four unique AR Manchester City Football Club Emoji figures of as gifts for users.

The CAMON 15 Pro, which is already available in the UAE, comes with 128GB ROM and 6GB RAM for a stable and highly efficient performance. It has a 4,000mAh battery, which enables stable power supply in work and daily life.

The TECNO CAMON 15 series has been highlighted through several platforms including the biggest flip book recorded by Guinness World Records ever.



About TECNO Mobile

Born in 2006, TECNO Mobile is a premium brand from TRANSSION HOLDINGS. As the first dual-SIM brand in Africa, TECNO is dedicated to transforming state-of-art technologies into localized products under the guideline "Think Globally, Act Locally". Since inception, TECNO has spread its presence in more than 40 countries across the world. Its product portfolio comprises smartphones, feature phones and tablets. As a fast-growing international brand, TECNO has achieved accumulative sales volume of 120 million units. It is one of the top three mobile brands in Africa and a global major player in industry. For more information please visit:www.tecno-mobile.com  

Contacts

Matrix PR
Melwyn Abraham, +97143430888
melwyn@matrixdubai.com


Permalink : https://www.aetoswire.com/news/tecno-unveils-camon-15-pro-via-online-launch-ndash-a-first-in-the-uae-amid-corona-crisis/en

Velodyne Lidar Announces Agreement with EasyMile

Velodyne Lidar Sensors Power EasyMile’s EZ10 Autonomous Vehicles




SAN JOSE, Calif-Thursday 30 April 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- Velodyne Lidar, Inc. today announced a three-year agreement with EasyMile, a global leader in driverless technology and smart vehicle solutions. EasyMile uses Velodyne lidar sensors in production of its EZ10 autonomous passenger shuttles that are deployed on public and private roads in more than 30 countries around the world.

EasyMile will enhance its EZ10 shuttle fleet with Velodyne’s state-of-the-art sensors for safe and efficient navigation on roadways. Electric and driverless, the EZ10 shuttle was the one of the first autonomous shuttles launched in April 2015. It has a track record of over 200 deployments and more than 600,000 km driven in autonomous mode and one of the most advanced technology currently available. The shuttle, which has capacity for up to 15 passengers, includes a built-in automated electric ramp to support accessibility for individuals with disabilities.

“For precise navigation in real time, the EZ10s use our algorithm that fuses data from a variety of perception sensors, including lidar and camera, and localization sensors, including GPS, INS and odometry. Velodyne lidars along with radar scan for objects, vehicles, animals and people that might pose a collision threat, feeding that information to the vehicle’s control software,” explained Olivier Pairot, EasyMile’s Director of Product Marketing. “By utilizing Velodyne sensors, we are able to best gather information on every part of our environment, both close to the vehicle and at longer ranges.”

“Velodyne’s high performance lidar technology is a key component in enabling our autonomous vehicles to deliver smart mobility in urban, suburban and private environments,” said Benoit Perrin, Managing Director and COO, EasyMile. “Velodyne’s solutions have the reliability, quality and production scale we are looking for to continue to grow our fleet worldwide.”

“The EasyMile EZ10 provides a shared, inclusive driverless shuttle solution that improves public transport by connecting hubs and in many cases, delivers a transport service where there otherwise wasn’t one available,” said Erich Smidt, Executive Director Europe, Velodyne Lidar. “These shuttles show how Velodyne lidar sensors provide real-time perception data that enables safe and reliable operation for autonomous vehicles across business parks, public transport connections, university campuses and more.”

Velodyne’s sensors are optimized for outstanding indoor and outdoor performance, operating in a variety of light conditions. By combining high-resolution 3D perception with a broad vertical field of view, they can accurately detect a variety of objects.

About Velodyne Lidar

Velodyne provides smart, powerful lidar solutions for autonomy and driver assistance. Headquartered in San Jose, Calif., Velodyne is known worldwide for its portfolio of breakthrough lidar sensor technologies. Velodyne’s founder, David Hall, invented real-time surround view lidar systems in 2005 as part of Velodyne Acoustics. Mr. Hall’s invention revolutionized perception and autonomy for automotive, new mobility, mapping, robotics, and security. Velodyne’s high-performance product line includes a broad range of sensing solutions, including the cost-effective Puck™, the versatile Ultra Puck™, the autonomy-advancing Alpha Prime™, the ADAS-optimized Velarray™, and the groundbreaking software for driver assistance, Vella™.

About EasyMile

EasyMile is a global leader in driverless technology and smart vehicle solutions. The fast-growing company develops software to automate transportation platforms without the need for dedicated infrastructure. EasyMile’s cutting-edge technology is revolutionizing passenger and goods transportation, offering new mobility options. EasyMile has already deployed close to 250 driverless projects in more than 30 countries and transported people over 600,000 km. Clients include the world’s largest transport operators, city authorities, airports, corporations, business parks, and universities. Founded in 2014, EasyMile has a global presence with headquarters in Toulouse (France) and regional offices in Denver (USA), Berlin (Germany), Adelaide (Australia) and Singapore. The Company employs over 200 highly skilled and passionate employees specializing in robotics, computer vision and vehicle dynamics. Besides the two founders, CEO Gilbert Gagnaire and Board Member Philippe Ligier, EasyMile benefits from the backing of minority shareholders and strategic partners, Alstom, Continental and Bpifrance.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200428005241/en/

Contacts
Press contact Velodyne Lidar, Inc.
Landis Communications Inc.
Sean Dowdall
(415) 286-7121, velodyne@landispr.com






Permalink : https://www.aetoswire.com/news/velodyne-lidar-announces-agreement-with-easymile/en

VELO3D Raises $28 Million in Series D Funding Round, Paving the Way for Product Expansion

Product portfolio will expand to deliver more machine options and compatible alloys to 3D print mission-critical metal parts for industrial applications

CAMPBELL, Calif.--(-Thursday 30 April 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- Digital manufacturing innovator VELO3D announced today that it has raised $28 million in a Series D funding round. New investors Piva and TNSC joined the round, along with existing investors Bessemer Venture Partners, Playground, and Khosla Ventures. This brings VELO3D’s total funding to $138 million.

“With the VELO3D integrated solution of Flow™ advanced pre-print software, Sapphire™ printer, and Assure™ quality management software, companies can finally break free of the constraints of existing metal additive manufacturing processes,” states Benny Buller, Founder and CEO of VELO3D. “Customers in industries such as aerospace, oil & gas, and power generation are now able to achieve part quality for their mission-critical applications with performance levels that weren’t possible before with 3D metal printing.”

VELO3D plans to use the new capital to expand its product portfolio to include more machine options, compatible alloys, and enhanced software and hardware capabilities. The company anticipates that the injection of fresh capital will help them reach sustainable profitability by mid-2022.

Piva is the largest investor in the new round and has a strong heritage in industrial markets, as they are backed by Malaysia-based PETRONAS, one of the world’s largest energy companies.

“VELO3D is revolutionizing the way we think about advanced manufacturing today,” said Ricardo Angel, CEO and Managing Partner at Piva. “We have been impressed by Benny, the team and their breakthrough technology that will have a significant impact on the efficient design and manufacturing of more complex components, previously unattainable, with clear commercial traction already in the aerospace and aviation markets. VELO3D will lead a new wave of more resilient, distributed manufacturing capabilities for its most critical components, which the world will need to ensure local product availability and timeliness, while mitigating potential future worldwide disruptions.”

Founded in 2015, VELO3D operated in stealth mode for the first 4 years, then announced availability of the Sapphire printer in 2019. In that first year of commercialization, VELO3D generated nearly $30 million in sales and gained seven new customers, many of which have placed repeat orders. VELO3D now has a global customer footprint that includes Japan, Korea, and Australia.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200428005135/en/

Contacts
VELO3D: Lynn Manning team@parkergroup.com


Permalink : https://www.aetoswire.com/news/velo3d-raises-28-million-in-series-d-funding-round-paving-the-way-for-product-expansion/en

MBC GROUP’S RAMADAN 2020 – A Superlative Record-Setting Season

Update brought to you by AMSI – A Choueiri Group brand

Dubai, United Arab Emirates, -Thursday 30 April 2020 [ AETOS Wire ]

As forecasted earlier, the surges in TV and VOD viewership due to the Covid-19 #STAY_AT_HOME situation have resulted in the region’s leading broadcasters achieving record performance figures.

The latest research spanning the first week of the Holy Month shows significant and ongoing increases in the time spent on MBC Group’s flagship TV Channels, as well as major boosts on the number of Shahid.net users and plays. (Vs. Ramadan 2019). For advertisers seeking impact, don’t miss out on this unmissable opportunity to become a part of MBC GROUP’s “Ramadan 2020” success story. 

Learn more, click on commercial.mbc.net/ramadan

Arabian Media Services International (AMSI) is a part of Choueiri Group and operates as the Exclusive Media Representative for MBC Group.

Contacts
Choueiri Group

Assad Jamil, +97144545454

ajamil.mr@choueirigroup.com

Permalink : https://www.aetoswire.com/news/mbc-grouprsquos-ramadan-2020-ndash-a-superlative-record-setting-season/en

Neuraptive Therapeutics Announces FDA Clearance of IND Application for NTX-001, a Novel Approach for the Treatment of Patients with Peripheral Nerve Injuries

• NTX-001 is a potentially transformative adjunctive treatment for peripheral nerve injuries, using a propriety system for the reconnection of severed nerves

• Neuraptive will conduct a Phase 2 Multicenter, Randomized, Controlled Study Evaluating the Safety and Efficacy of NTX-001 versus Standard of Care in Patients with Acute Single Transected Peripheral Nerve Injuries of the Upper Extremities

PHILADELPHIA-Thursday 30 April 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- Neuraptive Therapeutics, Inc. (Neuraptive), a clinical-stage biotechnology company dedicated to developing novel therapeutics and medical products to address the unmet needs in the treatment of peripheral nerve injuries (PNI), today announced that the U.S. Food and Drug Administration (FDA) has cleared Neuraptive's Investigational New Drug (IND) application for NTX-001 in patients with acute single transected PNI.

"We are pleased to have received clearance for the company’s first IND, and are excited to initiate the trial later this year," said Evan Tzanis, Executive Vice President and Head of Research and Development. "We look forward to working with investigators as we advance Neuraptive’s NTX-001 into the clinic for the treatment of peripheral nerve injuries."

Peripheral nerve injuries resulting in surgeries are common, occurring in more than 600,000 patients annually in the United States, with approximately 80% of nerve injuries occur in the upper extremities. Neuraptive’s Phase 2 study will evaluate the safety and efficacy of NTX-001 versus the current standard of care in upper extremity injuries. NTX-001 is being developed in the U.S. via the FDA 505 (b) (2) development pathway, in which the components contained in the product are present in existing, approved drug products, allowing for the potential of a more streamlined development program.

"Current interventions do not prevent the irreversible degeneration that occurs within 48 to 72 hours following injury. We believe that NTX-001 has the potential to diminish or prevent this degenerative process so that nerves recover more quickly, and patients can avoid disabilities that commonly result from these types of nerve injuries," said Ivan Gergel, MD, Executive Chairman of the Board of Neuraptive. "We are hopeful that NTX-001 can be a revolutionary treatment for physicians to offer their patients undergoing PNI repairs."

About Neuraptive Therapeutics

Neuraptive is creating innovative novel therapies for nerve repairs to improve clinical outcomes for patients and surgeons who care for them. The company's franchise therapeutic product, NTX-001, has the potential to improve the quality and speed of recovery of nerve sensation and function for eligible patients who have sustained traumatic injuries or who are undergoing reconstructive surgical procedures. Neuraptive is rapidly advancing its pipeline and will leverage its capabilities to transition into a clinical-stage company. Investors include New Rhein Healthcare Investors through its Fund 18 and Ben Franklin Technology Partners. The company is headquartered in Philadelphia, PA, and has offices near Boulder, CO, as well as surgical translational medical facilities at the Colorado University Anschutz Medical Center in Aurora, CO. For more information, see www.neuraptive.com.

About New Rhein Healthcare Investors

New Rhein is a venture capital/early growth stage fund manager whose investment strategy focuses on proven molecules used in new ways, such as new delivery forms and potential new uses and indications. In this way, New Rhein limits science-based risk and concentrates on development and execution. Prior investments have included medicines for Alzheimer’s disease, ophthalmic disorders, respiratory disease, and molecular oncology diagnostics. New Rhein’s partners, associates, and advisors are knowledgeable former industry executives with solid track records of operational, investment, and transactional experience. New Rhein combines significant deal-making expertise with deep operating experience, allowing it to tailor the right deal for the right situation and work with its portfolio companies to achieve maximum value for their products. For more information, see www.newrhein.com.

Cautionary Note on Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. including, among others, statements we make regarding the time for the commencement of clinical trials. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, anticipated events and trends, the economy and other future conditions and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200428005968/en/

Contacts
Investor Relations Neuraptive Therapeutics, Inc
IR@neuraptive.com

Evan Tzanis
Phone: +1-484-787-3203

Permalink : https://www.aetoswire.com/news/neuraptive-therapeutics-announces-fda-clearance-of-ind-application-for-ntx-001-a-novel-approach-for-the-treatment-of-patients-with-peripheral-nerve-injuries/en

Radicle Growth and Syngenta Launch The Radicle Protein Challenge by Syngenta to Invest $1.25m in Technologies to Support the Future of Protein

Application Period Open Through May 29; Calls on Companies of All Stages Solving Protein Challenges from Plant-Based to Regenerative Ag to Apply for Funding



SAN DIEGO-Wednesday 29 April 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- Radicle Growth, an acceleration fund, and Syngenta, a leading agriculture company helping to improve global food security, today announced the launch of The Radicle Protein Challenge by Syngenta. Together, Radicle and Syngenta will identify two companies with novel solutions to support the future of protein (which could include new or experimental protein sources, or protein conversion technologies) that are solving challenges spanning from plant-based ag to the regenerative side of agriculture, to invest $1.25m in.

Radicle and Syngenta are seeking entrepreneurs representing companies of all stages from around the world to apply for the $1.25 million in investment—$1 million for the Challenge winner and the $250k for the second-place winner—to accelerate the growth of their technologies. Applications are open through May 29, 2020. The winners will not only receive a significant investment and custom accelerator program from Radicle Growth but will have access to Radicle and Syngenta’s broad agriculture expertise and global agtech networks to advance and promote their technology.

“Innovative protein sources are increasingly important for a growing population. We are excited to be collaborating with Radicle and entrepreneurs from around the world to accelerate innovation and I am looking forward to seeing lots of creative ideas,” said Erik Fyrwald, CEO, Syngenta. “Our mission at Syngenta of helping farmers to make the best use of available resources and grow the crops we need in an environmentally friendly and healthy way, includes providing them with the best products, technologies and agronomic advice.”

After entries close, several months of due diligence work will begin and 4-6 finalists will be identified from the pool of applicants. The finalists will participate in a Pitch Day competition this Fall. Each company will have the opportunity to present in front of a leading panel of judges, including Erik Fyrwald, who will deliberate and select the two winners.

“Recent Gallup data confirms that nearly a quarter of Americans are eating less meat than ever before. This has increased the demand for plant-based and cellular agriculture alternatives to traditional protein sources,” said Kirk Haney, Managing Partner of Radicle Growth. “Many companies focused on this space have been hard at work with plans to launch in the near-term. Getting the product right to meet consumer demand is only half the battle, the pricing also needs to be right. We look forward to seeing the companies emerging in, and looking to grow, in this space and providing them the capital they need to overcome the challenges of growing this segment and staying ahead of consumer demands.”

For more information on The Radicle Protein Challenge by Syngenta, visit http://radicle.vc/the-radicle-challenge/.

About Radicle Growth
Radicle Growth is a San Diego-based acceleration fund that selects innovative agtech and food tech startups for investment, ensuring that powerful, disruptive technologies reach their full potential. In addition to providing seed-stage capital, they provide a fertile environment for visionaries in the ag space to flourish. Their proprietary platform is one of a kind in the agriculture industry, filling a huge void in the market by identifying the most innovative technologies and accelerating them with a range of value-creation initiatives. To connect and learn more about Radicle Growth follow us on LinkedIn, Instagram, Twitter.

About Syngenta
Syngenta is one of the world’s leading agriculture companies. Our ambition is to help safely feed the world while taking care of the planet. We aim to improve the sustainability, quality and safety of agriculture with world class science and innovative crop solutions. Our technologies enable millions of farmers around the world to make better use of limited agricultural resources. With 28,000 people in more than 90 countries we are working to transform how crops are grown. Through partnerships, collaboration and The Good Growth Plan we are committed to improving farm productivity, rescuing land from degradation, enhancing biodiversity and revitalizing rural communities. To learn more visit www.syngenta.com and www.goodgrowthplan.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200428005037/en/

Contacts

Danielle Dougan for Radicle Growth
ddougan@radicle.vc
978-430-9680

Permalink : https://www.aetoswire.com/news/radicle-growth-and-syngenta-launch-the-radicle-protein-challenge-by-syngenta-to-invest-125m-in-technologies-to-support-the-future-of-protein/en